Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23956184

Cumulative cisplatin dose is not associated with event-free or overall survival in children with newly diagnosed average-risk medulloblastoma treated with cisplatin based adjuvant chemotherapy: report from the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2014 Jan
First author
Nageswara Rao AA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Nageswara Rao AA
      type
      Author
    2. name
      Wallace DJ
      type
      Author
    3. name
      Billups C
      type
      Author
    4. name
      Boyett JM
      type
      Author
    5. name
      Gajjar A
      type
      Author
    6. name
      Packer RJ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Nageswara Rao AA
      type
      Author
    2. name
      Wallace DJ
      type
      Author
    3. name
      Billups C
      type
      Author
    4. name
      Boyett JM
      type
      Author
    5. name
      Gajjar A
      type
      Author
    6. name
      Packer RJ
      type
      Author
    bibliography ids
    1. nci-bib-fea954d6304d64db34fbe59b
    book metadata
    content sha256
    43505a4c45a2f14f73f8942be0eeaccd1f689a3045b072bacdc752154a79ba87
    document type
    citation
    dois
    1. 10.1002/pbc.24670
    electronic publication date
    display
    2013 Aug 19
    precision
    day
    year
    2013
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:23956184
    immutable id
    pubmed:23956184@43505a4c45a2f14f73f8942be0eeaccd1f689a3045b072bacdc752154a79ba87
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    1
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    102-6
    volume
    61
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      23956184
      provenance
      batch id
      0a08f044391426feb8ef
      provider
      NCBI PubMed ESummary
      record sha256
      bef265b98628853171c1d39e4a38e95673e4b15243de5d36bc4e3fdc7943cee0
      response sha256
      d94e6242343e5962374663e5e5f0191e7b595329228d2e360db95a280e588409
      retrieved at
      2026-09-09T23:46:57.614689+00:00
      publication date
      display
      2014 Jan
      precision
      month
      year
      2014
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/23956184/
      title
      Cumulative cisplatin dose is not associated with event-free or overall survival in children with newly diagnosed average-risk medulloblastoma treated with cisplatin based adjuvant chemotherapy: report from the Children's Oncology Group.

      Preserved source evidence · Not medical advice